ARRAY BIOPHARMA ANNOUNCES DRUG DISCOVERY COLLABORATION WITH ONO PHARMACEUTICAL CO., LTD.

Array BioPharma Inc. ("Array") (Nasdaq: ARRY) today announced the commencement of a drug discovery collaboration with Ono Pharmaceutical Co., Ltd. ("Ono") to create small molecule drug candidates against a series of kinases selected by Ono. "We dedicate ourselves on creating innovative medicines," said Kigen Kondo, Ph.D., Executive Director of Research Headquarters, Ono. "We are very much pleased about this collaborative arrangement with Array, a pharmaceutical company with excellent state-of-the-art technologies, to create drug candidates modulating our selected new targets."

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/11-03-2005/0004208278&EDATE=)